Chemistry:Oxabolone cipionate
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Trade names | Steranabol Depo, Steranabol Ritardo |
Other names | Oxabolone cypionate; FI-5852; 4-Hydroxy-19-nortestosterone 17β-cypionate; Estr-4-en-4,17β-diol-3-one 17β-cypionate |
Routes of administration | Intramuscular injection[1] |
Drug class | Androgen; Anabolic steroid; Androgen ester |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C26H38O4 |
Molar mass | 414.586 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Oxabolone cipionate (INN, JAN) (brand names Steranabol Depo, Steranabol Ritardo; former developmental code name FI-5852), or oxabolone cypionate, also known as 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic and injected anabolic–androgenic steroid (AAS) and derivative of nandrolone (19-nortestosterone) which has been marketed in Europe.[1][2][3] It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).[2][3]
See also
- 4-Hydroxytestosterone
- Clostebol (4-chlorotestosterone)
- Formestane (4-hydroxyandrostenedione)
- Norclostebol (4-chloro-19-nortestosterone)
References
- ↑ 1.0 1.1 Anabolic Steroids. Elsevier. 22 October 2013. pp. 203–. ISBN 978-1-4832-6504-9. https://books.google.com/books?id=4xIlBQAAQBAJ&pg=PA203.
- ↑ 2.0 2.1 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 764–765. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA764.
- ↑ 3.0 3.1 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014. pp. 1–. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=RA1-PA538.
{{Navbox
| name = Androgens and antiandrogens | title = Androgens and antiandrogens | state = collapsed | listclass = hlist | groupstyle = text-align:center;
| group1 = Androgens
(incl. AAS)
| list1 =
| group2 = Antiandrogens | list2 = {{Navbox|child | groupstyle = text-align:center; | groupwidth = 9em;
| group1 = AR antagonists | list1 =
- Steroidal: Abiraterone acetate
- Canrenone
- Chlormadinone acetate
- Cyproterone acetate
- Delmadinone acetate
- Dienogest
- Drospirenone
- Medrogestone
- Megestrol acetate
- Nomegestrol acetate
- Osaterone acetate
- Oxendolone
- Potassium canrenoate
- Spironolactone
- Nonsteroidal: Apalutamide
- Bicalutamide
- Cimetidine
- Darolutamide
- Enzalutamide
- Flutamide
- Ketoconazole
- Nilutamide
- Seviteronel†
- Topilutamide (fluridil)
| group2 = Steroidogenesis| list2 =
inhibitors
5α-Reductase | |
---|---|
Others |
| group3 = Antigonadotropins | list3 =
- D2 receptor antagonists (prolactin releasers) (e.g., domperidone, metoclopramide, risperidone, haloperidol, chlorpromazine, sulpiride)
- Estrogens (e.g., bifluranol, [[diethylstilbestrol, estradiol, estradiol esters, ethinylestradiol, ethinylestradiol sulfonate, paroxypropione)
- GnRH agonists (e.g., leuprorelin)
- GnRH antagonists (e.g., cetrorelix)
- Progestogens (incl., chlormadinone acetate, [[cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, [[Chemistry:Medroxyprogesterone medroxyprogesterone acetate, Chemistry:Megestrol acetate|megestrol acetate]])
| group4 = Others | list4 =
- Androstenedione immunogens: Androvax (androstenedione albumin)
- Ovandrotone albumin (Fecundin)
}}
| liststyle = background:#DDDDFF;| list3 =
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Androgen receptor modulators
- Estrogens and antiestrogens
- Progestogens and antiprogestogens
- List of androgens/anabolic steroids
}}
Original source: https://en.wikipedia.org/wiki/Oxabolone cipionate.
Read more |